| License: Creative Commons Attribution 4.0 PDF - Published Version (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-774378
- DOI to cite this document:
- 10.5283/epub.77437
This publication is part of the DEAL contract with Springer.
Abstract
Background Pyogenic vertebral osteomyelitis (PVO) presents an escalating clinical challenge due to rising incidence, high mortality, and significant bone destruction. Objective quantification of vertebral body (VB) bone loss for assessing the disease severity and guiding therapeutic decisions is yet to be established. Methods We retrospectively identified patients with confirmed PVO between ...

Owner only: item control page

Download Statistics